Summary

The global Pet Disease Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
These drugs are used to quiet anxious pets or help in reducing anxiety associated with various behavioral issues in pets.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly ?6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 51%.
LP Information, Inc. (LPI) ' newest research report, the “Pet Disease Drugs Industry Forecast” looks at past sales and reviews total world Pet Disease Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Pet Disease Drugs sales for 2026 through 2032. With Pet Disease Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Disease Drugs industry.
This Insight Report provides a comprehensive analysis of the global Pet Disease Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Disease Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pet Disease Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Disease Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Disease Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Disease Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Parasiticides
Anti-infectives
Anti-inflammatory
Analgesics
Others
Segmentation by Application:
Infectious Diseases
Dermatologic Diseases
Pain
Orthopedic Diseases
Behavioral Diseases
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck & Co., Inc.
Ceva
Vetoquinol S.A.
Zoetis
Virbac
Bimeda
Calier
Boehringer Ingelheim
Elanco Animal Health
Dechra Pharmaceuticals
Norbrook Laboratories
Chanelle Pharma
K-Laser USA
Assisi Animal Health
Multi Radiance Medical
Avazzia
SOUND Technologies
IRM Enterprises
Ashish Life Science
Century Pharmaceuticals
VETINDIA Pharmaceuticals
Ourofino Animal Health
SeQuent Scientific
LABINDIA Healthcare
Morvel Laboratories
Richter Pharma
Zuche Pharmaceuticals
Fidelis Animal Health
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pet Disease Drugs market?
What factors are driving Pet Disease Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Disease Drugs market opportunities vary by end market size?
How does Pet Disease Drugs break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pet Disease Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pet Disease Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pet Disease Drugs by Country/Region, 2021, 2025 & 2032
2.2 Pet Disease Drugs Segment by Type
2.2.1 Parasiticides
2.2.2 Anti-infectives
2.2.3 Anti-inflammatory
2.2.4 Analgesics
2.2.5 Others
2.2.6 Pet Disease Drugs Sales by Type
2.2.6.1 Global Pet Disease Drugs Sales Market Share by Type (2021-2026)
2.2.6.2 Global Pet Disease Drugs Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Pet Disease Drugs Sale Price by Type (2021-2026)
2.3 Pet Disease Drugs Segment by Application
2.3.1 Infectious Diseases
2.3.2 Dermatologic Diseases
2.3.3 Pain
2.3.4 Orthopedic Diseases
2.3.5 Behavioral Diseases
2.3.6 Other
2.3.7 Pet Disease Drugs Sales by Application
2.3.7.1 Global Pet Disease Drugs Sale Market Share by Application (2021-2026)
2.3.7.2 Global Pet Disease Drugs Revenue and Market Share by Application (2021-2026)
2.3.7.3 Global Pet Disease Drugs Sale Price by Application (2021-2026)
3 Global by Company
3.1 Global Pet Disease Drugs Breakdown Data by Company
3.1.1 Global Pet Disease Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Pet Disease Drugs Sales Market Share by Company (2021-2026)
3.2 Global Pet Disease Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Pet Disease Drugs Revenue by Company (2021-2026)
3.2.2 Global Pet Disease Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Pet Disease Drugs Sale Price by Company
3.4 Key Manufacturers Pet Disease Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Disease Drugs Product Location Distribution
3.4.2 Players Pet Disease Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pet Disease Drugs by Geographic Region
4.1 World Historic Pet Disease Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Pet Disease Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pet Disease Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pet Disease Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Pet Disease Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pet Disease Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pet Disease Drugs Sales Growth
4.4 APAC Pet Disease Drugs Sales Growth
4.5 Europe Pet Disease Drugs Sales Growth
4.6 Middle East & Africa Pet Disease Drugs Sales Growth
5 Americas
5.1 Americas Pet Disease Drugs Sales by Country
5.1.1 Americas Pet Disease Drugs Sales by Country (2021-2026)
5.1.2 Americas Pet Disease Drugs Revenue by Country (2021-2026)
5.2 Americas Pet Disease Drugs Sales by Type (2021-2026)
5.3 Americas Pet Disease Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Disease Drugs Sales by Region
6.1.1 APAC Pet Disease Drugs Sales by Region (2021-2026)
6.1.2 APAC Pet Disease Drugs Revenue by Region (2021-2026)
6.2 APAC Pet Disease Drugs Sales by Type (2021-2026)
6.3 APAC Pet Disease Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pet Disease Drugs by Country
7.1.1 Europe Pet Disease Drugs Sales by Country (2021-2026)
7.1.2 Europe Pet Disease Drugs Revenue by Country (2021-2026)
7.2 Europe Pet Disease Drugs Sales by Type (2021-2026)
7.3 Europe Pet Disease Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pet Disease Drugs by Country
8.1.1 Middle East & Africa Pet Disease Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pet Disease Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Pet Disease Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Pet Disease Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Disease Drugs
10.3 Manufacturing Process Analysis of Pet Disease Drugs
10.4 Industry Chain Structure of Pet Disease Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Disease Drugs Distributors
11.3 Pet Disease Drugs Customer
12 World Forecast Review for Pet Disease Drugs by Geographic Region
12.1 Global Pet Disease Drugs Market Size Forecast by Region
12.1.1 Global Pet Disease Drugs Forecast by Region (2027-2032)
12.1.2 Global Pet Disease Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pet Disease Drugs Forecast by Type (2027-2032)
12.7 Global Pet Disease Drugs Forecast by Application (2027-2032)
13 Key Players Analysis
13.1 Merck & Co., Inc.
13.1.1 Merck & Co., Inc. Company Information
13.1.2 Merck & Co., Inc. Pet Disease Drugs Product Portfolios and Specifications
13.1.3 Merck & Co., Inc. Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck & Co., Inc. Main Business Overview
13.1.5 Merck & Co., Inc. Latest Developments
13.2 Ceva
13.2.1 Ceva Company Information
13.2.2 Ceva Pet Disease Drugs Product Portfolios and Specifications
13.2.3 Ceva Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Ceva Main Business Overview
13.2.5 Ceva Latest Developments
13.3 Vetoquinol S.A.
13.3.1 Vetoquinol S.A. Company Information
13.3.2 Vetoquinol S.A. Pet Disease Drugs Product Portfolios and Specifications
13.3.3 Vetoquinol S.A. Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Vetoquinol S.A. Main Business Overview
13.3.5 Vetoquinol S.A. Latest Developments
13.4 Zoetis
13.4.1 Zoetis Company Information
13.4.2 Zoetis Pet Disease Drugs Product Portfolios and Specifications
13.4.3 Zoetis Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Zoetis Main Business Overview
13.4.5 Zoetis Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Pet Disease Drugs Product Portfolios and Specifications
13.5.3 Virbac Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 Bimeda
13.6.1 Bimeda Company Information
13.6.2 Bimeda Pet Disease Drugs Product Portfolios and Specifications
13.6.3 Bimeda Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Bimeda Main Business Overview
13.6.5 Bimeda Latest Developments
13.7 Calier
13.7.1 Calier Company Information
13.7.2 Calier Pet Disease Drugs Product Portfolios and Specifications
13.7.3 Calier Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Calier Main Business Overview
13.7.5 Calier Latest Developments
13.8 Boehringer Ingelheim
13.8.1 Boehringer Ingelheim Company Information
13.8.2 Boehringer Ingelheim Pet Disease Drugs Product Portfolios and Specifications
13.8.3 Boehringer Ingelheim Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Boehringer Ingelheim Main Business Overview
13.8.5 Boehringer Ingelheim Latest Developments
13.9 Elanco Animal Health
13.9.1 Elanco Animal Health Company Information
13.9.2 Elanco Animal Health Pet Disease Drugs Product Portfolios and Specifications
13.9.3 Elanco Animal Health Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Elanco Animal Health Main Business Overview
13.9.5 Elanco Animal Health Latest Developments
13.10 Dechra Pharmaceuticals
13.10.1 Dechra Pharmaceuticals Company Information
13.10.2 Dechra Pharmaceuticals Pet Disease Drugs Product Portfolios and Specifications
13.10.3 Dechra Pharmaceuticals Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Dechra Pharmaceuticals Main Business Overview
13.10.5 Dechra Pharmaceuticals Latest Developments
13.11 Norbrook Laboratories
13.11.1 Norbrook Laboratories Company Information
13.11.2 Norbrook Laboratories Pet Disease Drugs Product Portfolios and Specifications
13.11.3 Norbrook Laboratories Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Norbrook Laboratories Main Business Overview
13.11.5 Norbrook Laboratories Latest Developments
13.12 Chanelle Pharma
13.12.1 Chanelle Pharma Company Information
13.12.2 Chanelle Pharma Pet Disease Drugs Product Portfolios and Specifications
13.12.3 Chanelle Pharma Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Chanelle Pharma Main Business Overview
13.12.5 Chanelle Pharma Latest Developments
13.13 K-Laser USA
13.13.1 K-Laser USA Company Information
13.13.2 K-Laser USA Pet Disease Drugs Product Portfolios and Specifications
13.13.3 K-Laser USA Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 K-Laser USA Main Business Overview
13.13.5 K-Laser USA Latest Developments
13.14 Assisi Animal Health
13.14.1 Assisi Animal Health Company Information
13.14.2 Assisi Animal Health Pet Disease Drugs Product Portfolios and Specifications
13.14.3 Assisi Animal Health Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Assisi Animal Health Main Business Overview
13.14.5 Assisi Animal Health Latest Developments
13.15 Multi Radiance Medical
13.15.1 Multi Radiance Medical Company Information
13.15.2 Multi Radiance Medical Pet Disease Drugs Product Portfolios and Specifications
13.15.3 Multi Radiance Medical Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Multi Radiance Medical Main Business Overview
13.15.5 Multi Radiance Medical Latest Developments
13.16 Avazzia
13.16.1 Avazzia Company Information
13.16.2 Avazzia Pet Disease Drugs Product Portfolios and Specifications
13.16.3 Avazzia Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Avazzia Main Business Overview
13.16.5 Avazzia Latest Developments
13.17 SOUND Technologies
13.17.1 SOUND Technologies Company Information
13.17.2 SOUND Technologies Pet Disease Drugs Product Portfolios and Specifications
13.17.3 SOUND Technologies Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 SOUND Technologies Main Business Overview
13.17.5 SOUND Technologies Latest Developments
13.18 IRM Enterprises
13.18.1 IRM Enterprises Company Information
13.18.2 IRM Enterprises Pet Disease Drugs Product Portfolios and Specifications
13.18.3 IRM Enterprises Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 IRM Enterprises Main Business Overview
13.18.5 IRM Enterprises Latest Developments
13.19 Ashish Life Science
13.19.1 Ashish Life Science Company Information
13.19.2 Ashish Life Science Pet Disease Drugs Product Portfolios and Specifications
13.19.3 Ashish Life Science Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Ashish Life Science Main Business Overview
13.19.5 Ashish Life Science Latest Developments
13.20 Century Pharmaceuticals
13.20.1 Century Pharmaceuticals Company Information
13.20.2 Century Pharmaceuticals Pet Disease Drugs Product Portfolios and Specifications
13.20.3 Century Pharmaceuticals Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Century Pharmaceuticals Main Business Overview
13.20.5 Century Pharmaceuticals Latest Developments
13.21 VETINDIA Pharmaceuticals
13.21.1 VETINDIA Pharmaceuticals Company Information
13.21.2 VETINDIA Pharmaceuticals Pet Disease Drugs Product Portfolios and Specifications
13.21.3 VETINDIA Pharmaceuticals Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 VETINDIA Pharmaceuticals Main Business Overview
13.21.5 VETINDIA Pharmaceuticals Latest Developments
13.22 Ourofino Animal Health
13.22.1 Ourofino Animal Health Company Information
13.22.2 Ourofino Animal Health Pet Disease Drugs Product Portfolios and Specifications
13.22.3 Ourofino Animal Health Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Ourofino Animal Health Main Business Overview
13.22.5 Ourofino Animal Health Latest Developments
13.23 SeQuent Scientific
13.23.1 SeQuent Scientific Company Information
13.23.2 SeQuent Scientific Pet Disease Drugs Product Portfolios and Specifications
13.23.3 SeQuent Scientific Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 SeQuent Scientific Main Business Overview
13.23.5 SeQuent Scientific Latest Developments
13.24 LABINDIA Healthcare
13.24.1 LABINDIA Healthcare Company Information
13.24.2 LABINDIA Healthcare Pet Disease Drugs Product Portfolios and Specifications
13.24.3 LABINDIA Healthcare Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 LABINDIA Healthcare Main Business Overview
13.24.5 LABINDIA Healthcare Latest Developments
13.25 Morvel Laboratories
13.25.1 Morvel Laboratories Company Information
13.25.2 Morvel Laboratories Pet Disease Drugs Product Portfolios and Specifications
13.25.3 Morvel Laboratories Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Morvel Laboratories Main Business Overview
13.25.5 Morvel Laboratories Latest Developments
13.26 Richter Pharma
13.26.1 Richter Pharma Company Information
13.26.2 Richter Pharma Pet Disease Drugs Product Portfolios and Specifications
13.26.3 Richter Pharma Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Richter Pharma Main Business Overview
13.26.5 Richter Pharma Latest Developments
13.27 Zuche Pharmaceuticals
13.27.1 Zuche Pharmaceuticals Company Information
13.27.2 Zuche Pharmaceuticals Pet Disease Drugs Product Portfolios and Specifications
13.27.3 Zuche Pharmaceuticals Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Zuche Pharmaceuticals Main Business Overview
13.27.5 Zuche Pharmaceuticals Latest Developments
13.28 Fidelis Animal Health
13.28.1 Fidelis Animal Health Company Information
13.28.2 Fidelis Animal Health Pet Disease Drugs Product Portfolios and Specifications
13.28.3 Fidelis Animal Health Pet Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 Fidelis Animal Health Main Business Overview
13.28.5 Fidelis Animal Health Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Pet Disease Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pet Disease Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Parasiticides
Table 4. Major Players of Anti-infectives
Table 5. Major Players of Anti-inflammatory
Table 6. Major Players of Analgesics
Table 7. Major Players of Others
Table 8. Global Pet Disease Drugs Sales by Type (2021-2026) & (K Units)
Table 9. Global Pet Disease Drugs Sales Market Share by Type (2021-2026)
Table 10. Global Pet Disease Drugs Revenue by Type (2021-2026) & ($ million)
Table 11. Global Pet Disease Drugs Revenue Market Share by Type (2021-2026)
Table 12. Global Pet Disease Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Pet Disease Drugs Sale by Application (2021-2026) & (K Units)
Table 14. Global Pet Disease Drugs Sale Market Share by Application (2021-2026)
Table 15. Global Pet Disease Drugs Revenue by Application (2021-2026) & ($ million)
Table 16. Global Pet Disease Drugs Revenue Market Share by Application (2021-2026)
Table 17. Global Pet Disease Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Pet Disease Drugs Sales by Company (2021-2026) & (K Units)
Table 19. Global Pet Disease Drugs Sales Market Share by Company (2021-2026)
Table 20. Global Pet Disease Drugs Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Pet Disease Drugs Revenue Market Share by Company (2021-2026)
Table 22. Global Pet Disease Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Pet Disease Drugs Producing Area Distribution and Sales Area
Table 24. Players Pet Disease Drugs Products Offered
Table 25. Pet Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Pet Disease Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Pet Disease Drugs Sales Market Share Geographic Region (2021-2026)
Table 30. Global Pet Disease Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Pet Disease Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Pet Disease Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Pet Disease Drugs Sales Market Share by Country/Region (2021-2026)
Table 34. Global Pet Disease Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Pet Disease Drugs Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Pet Disease Drugs Sales by Country (2021-2026) & (K Units)
Table 37. Americas Pet Disease Drugs Sales Market Share by Country (2021-2026)
Table 38. Americas Pet Disease Drugs Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Pet Disease Drugs Sales by Type (2021-2026) & (K Units)
Table 40. Americas Pet Disease Drugs Sales by Application (2021-2026) & (K Units)
Table 41. APAC Pet Disease Drugs Sales by Region (2021-2026) & (K Units)
Table 42. APAC Pet Disease Drugs Sales Market Share by Region (2021-2026)
Table 43. APAC Pet Disease Drugs Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Pet Disease Drugs Sales by Type (2021-2026) & (K Units)
Table 45. APAC Pet Disease Drugs Sales by Application (2021-2026) & (K Units)
Table 46. Europe Pet Disease Drugs Sales by Country (2021-2026) & (K Units)
Table 47. Europe Pet Disease Drugs Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Pet Disease Drugs Sales by Type (2021-2026) & (K Units)
Table 49. Europe Pet Disease Drugs Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Pet Disease Drugs Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Pet Disease Drugs Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Pet Disease Drugs Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Pet Disease Drugs Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Pet Disease Drugs
Table 55. Key Market Challenges & Risks of Pet Disease Drugs
Table 56. Key Industry Trends of Pet Disease Drugs
Table 57. Pet Disease Drugs Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Pet Disease Drugs Distributors List
Table 60. Pet Disease Drugs Customer List
Table 61. Global Pet Disease Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Pet Disease Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Pet Disease Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Pet Disease Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Pet Disease Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Pet Disease Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Pet Disease Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Pet Disease Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Pet Disease Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Pet Disease Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Pet Disease Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Pet Disease Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Pet Disease Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Pet Disease Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Merck & Co., Inc. Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Merck & Co., Inc. Pet Disease Drugs Product Portfolios and Specifications
Table 77. Merck & Co., Inc. Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Merck & Co., Inc. Main Business
Table 79. Merck & Co., Inc. Latest Developments
Table 80. Ceva Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Ceva Pet Disease Drugs Product Portfolios and Specifications
Table 82. Ceva Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Ceva Main Business
Table 84. Ceva Latest Developments
Table 85. Vetoquinol S.A. Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Vetoquinol S.A. Pet Disease Drugs Product Portfolios and Specifications
Table 87. Vetoquinol S.A. Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Vetoquinol S.A. Main Business
Table 89. Vetoquinol S.A. Latest Developments
Table 90. Zoetis Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Zoetis Pet Disease Drugs Product Portfolios and Specifications
Table 92. Zoetis Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Zoetis Main Business
Table 94. Zoetis Latest Developments
Table 95. Virbac Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Virbac Pet Disease Drugs Product Portfolios and Specifications
Table 97. Virbac Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Virbac Main Business
Table 99. Virbac Latest Developments
Table 100. Bimeda Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Bimeda Pet Disease Drugs Product Portfolios and Specifications
Table 102. Bimeda Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Bimeda Main Business
Table 104. Bimeda Latest Developments
Table 105. Calier Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Calier Pet Disease Drugs Product Portfolios and Specifications
Table 107. Calier Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Calier Main Business
Table 109. Calier Latest Developments
Table 110. Boehringer Ingelheim Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Boehringer Ingelheim Pet Disease Drugs Product Portfolios and Specifications
Table 112. Boehringer Ingelheim Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Boehringer Ingelheim Main Business
Table 114. Boehringer Ingelheim Latest Developments
Table 115. Elanco Animal Health Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Elanco Animal Health Pet Disease Drugs Product Portfolios and Specifications
Table 117. Elanco Animal Health Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Elanco Animal Health Main Business
Table 119. Elanco Animal Health Latest Developments
Table 120. Dechra Pharmaceuticals Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Dechra Pharmaceuticals Pet Disease Drugs Product Portfolios and Specifications
Table 122. Dechra Pharmaceuticals Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Dechra Pharmaceuticals Main Business
Table 124. Dechra Pharmaceuticals Latest Developments
Table 125. Norbrook Laboratories Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Norbrook Laboratories Pet Disease Drugs Product Portfolios and Specifications
Table 127. Norbrook Laboratories Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Norbrook Laboratories Main Business
Table 129. Norbrook Laboratories Latest Developments
Table 130. Chanelle Pharma Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Chanelle Pharma Pet Disease Drugs Product Portfolios and Specifications
Table 132. Chanelle Pharma Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Chanelle Pharma Main Business
Table 134. Chanelle Pharma Latest Developments
Table 135. K-Laser USA Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. K-Laser USA Pet Disease Drugs Product Portfolios and Specifications
Table 137. K-Laser USA Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. K-Laser USA Main Business
Table 139. K-Laser USA Latest Developments
Table 140. Assisi Animal Health Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Assisi Animal Health Pet Disease Drugs Product Portfolios and Specifications
Table 142. Assisi Animal Health Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Assisi Animal Health Main Business
Table 144. Assisi Animal Health Latest Developments
Table 145. Multi Radiance Medical Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Multi Radiance Medical Pet Disease Drugs Product Portfolios and Specifications
Table 147. Multi Radiance Medical Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Multi Radiance Medical Main Business
Table 149. Multi Radiance Medical Latest Developments
Table 150. Avazzia Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Avazzia Pet Disease Drugs Product Portfolios and Specifications
Table 152. Avazzia Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Avazzia Main Business
Table 154. Avazzia Latest Developments
Table 155. SOUND Technologies Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. SOUND Technologies Pet Disease Drugs Product Portfolios and Specifications
Table 157. SOUND Technologies Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. SOUND Technologies Main Business
Table 159. SOUND Technologies Latest Developments
Table 160. IRM Enterprises Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 161. IRM Enterprises Pet Disease Drugs Product Portfolios and Specifications
Table 162. IRM Enterprises Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. IRM Enterprises Main Business
Table 164. IRM Enterprises Latest Developments
Table 165. Ashish Life Science Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 166. Ashish Life Science Pet Disease Drugs Product Portfolios and Specifications
Table 167. Ashish Life Science Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Ashish Life Science Main Business
Table 169. Ashish Life Science Latest Developments
Table 170. Century Pharmaceuticals Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 171. Century Pharmaceuticals Pet Disease Drugs Product Portfolios and Specifications
Table 172. Century Pharmaceuticals Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. Century Pharmaceuticals Main Business
Table 174. Century Pharmaceuticals Latest Developments
Table 175. VETINDIA Pharmaceuticals Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 176. VETINDIA Pharmaceuticals Pet Disease Drugs Product Portfolios and Specifications
Table 177. VETINDIA Pharmaceuticals Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. VETINDIA Pharmaceuticals Main Business
Table 179. VETINDIA Pharmaceuticals Latest Developments
Table 180. Ourofino Animal Health Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 181. Ourofino Animal Health Pet Disease Drugs Product Portfolios and Specifications
Table 182. Ourofino Animal Health Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 183. Ourofino Animal Health Main Business
Table 184. Ourofino Animal Health Latest Developments
Table 185. SeQuent Scientific Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 186. SeQuent Scientific Pet Disease Drugs Product Portfolios and Specifications
Table 187. SeQuent Scientific Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 188. SeQuent Scientific Main Business
Table 189. SeQuent Scientific Latest Developments
Table 190. LABINDIA Healthcare Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 191. LABINDIA Healthcare Pet Disease Drugs Product Portfolios and Specifications
Table 192. LABINDIA Healthcare Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 193. LABINDIA Healthcare Main Business
Table 194. LABINDIA Healthcare Latest Developments
Table 195. Morvel Laboratories Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 196. Morvel Laboratories Pet Disease Drugs Product Portfolios and Specifications
Table 197. Morvel Laboratories Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 198. Morvel Laboratories Main Business
Table 199. Morvel Laboratories Latest Developments
Table 200. Richter Pharma Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 201. Richter Pharma Pet Disease Drugs Product Portfolios and Specifications
Table 202. Richter Pharma Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 203. Richter Pharma Main Business
Table 204. Richter Pharma Latest Developments
Table 205. Zuche Pharmaceuticals Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 206. Zuche Pharmaceuticals Pet Disease Drugs Product Portfolios and Specifications
Table 207. Zuche Pharmaceuticals Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 208. Zuche Pharmaceuticals Main Business
Table 209. Zuche Pharmaceuticals Latest Developments
Table 210. Fidelis Animal Health Basic Information, Pet Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 211. Fidelis Animal Health Pet Disease Drugs Product Portfolios and Specifications
Table 212. Fidelis Animal Health Pet Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 213. Fidelis Animal Health Main Business
Table 214. Fidelis Animal Health Latest Developments


List of Figures
Figure 1. Picture of Pet Disease Drugs
Figure 2. Pet Disease Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Disease Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pet Disease Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pet Disease Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pet Disease Drugs Sales Market Share by Country/Region (2025)
Figure 10. Pet Disease Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Parasiticides
Figure 12. Product Picture of Anti-infectives
Figure 13. Product Picture of Anti-inflammatory
Figure 14. Product Picture of Analgesics
Figure 15. Product Picture of Others
Figure 16. Global Pet Disease Drugs Sales Market Share by Type in 2026
Figure 17. Global Pet Disease Drugs Revenue Market Share by Type (2021-2026)
Figure 18. Pet Disease Drugs Consumed in Infectious Diseases
Figure 19. Global Pet Disease Drugs Market: Infectious Diseases (2021-2026) & (K Units)
Figure 20. Pet Disease Drugs Consumed in Dermatologic Diseases
Figure 21. Global Pet Disease Drugs Market: Dermatologic Diseases (2021-2026) & (K Units)
Figure 22. Pet Disease Drugs Consumed in Pain
Figure 23. Global Pet Disease Drugs Market: Pain (2021-2026) & (K Units)
Figure 24. Pet Disease Drugs Consumed in Orthopedic Diseases
Figure 25. Global Pet Disease Drugs Market: Orthopedic Diseases (2021-2026) & (K Units)
Figure 26. Pet Disease Drugs Consumed in Behavioral Diseases
Figure 27. Global Pet Disease Drugs Market: Behavioral Diseases (2021-2026) & (K Units)
Figure 28. Pet Disease Drugs Consumed in Other
Figure 29. Global Pet Disease Drugs Market: Other (2021-2026) & (K Units)
Figure 30. Global Pet Disease Drugs Sale Market Share by Application (2025)
Figure 31. Global Pet Disease Drugs Revenue Market Share by Application in 2026
Figure 32. Pet Disease Drugs Sales by Company in 2026 (K Units)
Figure 33. Global Pet Disease Drugs Sales Market Share by Company in 2026
Figure 34. Pet Disease Drugs Revenue by Company in 2026 ($ millions)
Figure 35. Global Pet Disease Drugs Revenue Market Share by Company in 2026
Figure 36. Global Pet Disease Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Pet Disease Drugs Revenue Market Share by Geographic Region in 2026
Figure 38. Americas Pet Disease Drugs Sales 2021-2026 (K Units)
Figure 39. Americas Pet Disease Drugs Revenue 2021-2026 ($ millions)
Figure 40. APAC Pet Disease Drugs Sales 2021-2026 (K Units)
Figure 41. APAC Pet Disease Drugs Revenue 2021-2026 ($ millions)
Figure 42. Europe Pet Disease Drugs Sales 2021-2026 (K Units)
Figure 43. Europe Pet Disease Drugs Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Pet Disease Drugs Sales 2021-2026 (K Units)
Figure 45. Middle East & Africa Pet Disease Drugs Revenue 2021-2026 ($ millions)
Figure 46. Americas Pet Disease Drugs Sales Market Share by Country in 2026
Figure 47. Americas Pet Disease Drugs Revenue Market Share by Country (2021-2026)
Figure 48. Americas Pet Disease Drugs Sales Market Share by Type (2021-2026)
Figure 49. Americas Pet Disease Drugs Sales Market Share by Application (2021-2026)
Figure 50. United States Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Pet Disease Drugs Sales Market Share by Region in 2026
Figure 55. APAC Pet Disease Drugs Revenue Market Share by Region (2021-2026)
Figure 56. APAC Pet Disease Drugs Sales Market Share by Type (2021-2026)
Figure 57. APAC Pet Disease Drugs Sales Market Share by Application (2021-2026)
Figure 58. China Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. India Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Pet Disease Drugs Sales Market Share by Country in 2026
Figure 66. Europe Pet Disease Drugs Revenue Market Share by Country (2021-2026)
Figure 67. Europe Pet Disease Drugs Sales Market Share by Type (2021-2026)
Figure 68. Europe Pet Disease Drugs Sales Market Share by Application (2021-2026)
Figure 69. Germany Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. France Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Pet Disease Drugs Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Pet Disease Drugs Sales Market Share by Type (2021-2026)
Figure 76. Middle East & Africa Pet Disease Drugs Sales Market Share by Application (2021-2026)
Figure 77. Egypt Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Pet Disease Drugs Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Pet Disease Drugs in 2026
Figure 83. Manufacturing Process Analysis of Pet Disease Drugs
Figure 84. Industry Chain Structure of Pet Disease Drugs
Figure 85. Channels of Distribution
Figure 86. Global Pet Disease Drugs Sales Market Forecast by Region (2027-2032)
Figure 87. Global Pet Disease Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Pet Disease Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 89. Global Pet Disease Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 90. Global Pet Disease Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Pet Disease Drugs Revenue Market Share Forecast by Application (2027-2032)